Aethlon Medical
AEMD0.662817.10% ( +0.0968 )
Aethlon Medical (AEMD)
Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices in the United States. It develops Hemopurifier, a cl...
- Open
- 0.5330
- High
- 0.7500
- Low
- 0.5330
- Prev. Close
- 0.5660
- Volume
- 1.28M
- Turnover
- 852.71K
- Avg Price
- 0.6670
- Bid/Ask Ratio
- --
- Amplitude
- 38.34%
- 52wk High
- 27.4000
- Volume Ratio
- 14.71
- Turnover Ratio
- 86.48%
Aethlon Medical Analyst Rating
View MoreForecast & Rating
Jun 11, 2026Price forecast
$3.25390.34%
Forecast & RatingHold
2analysts
- Strong buy0.00%
- Buy0.00%
- Hold100.00%
- Sell0.00%
- Strong sell0.00%
News
- PUBT · 2 days ago, 07:04 AM
Aethlon Medical effects 1-for-5 reverse stock split
- PUBT · Jul 13 at 07:06 AM
Aethlon Medical reports biomarker shifts in second cohort of Hemopurifier cancer trial
- StockTitan · Jul 12 at 11:01 PM
Aethlon Medical Continues to Observe Directional Changes in Second Cohort of Australian Oncology Clinical Trial Evaluating Hemopurifier® | AEMD Stock News
- TradingView · Jul 8 at 05:03 AM
Aethlon Medical Raises ~$4.0 Million in Registered Offering Priced at $0.71; Maxim Group as Agent
- PUBT · Jul 6 at 08:28 AM
Aethlon Medical prices $4 million offering with warrants exercisable at $0.71 on shareholder approval
- StockTitan · Jul 6 at 12:25 AM
Aethlon Medical Announces Pricing of $4.0 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules | AEMD Stock News
